-
1
-
-
27644447206
-
Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma
-
K. Mascia, T. Haselkorn, Y.M. Deniz, and et al. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma J Allergy Clin Immunol 116 2005 970 975
-
(2005)
J Allergy Clin Immunol
, vol.116
, pp. 970-975
-
-
Mascia, K.1
Haselkorn, T.2
Deniz, Y.M.3
-
2
-
-
0037391750
-
2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge
-
2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge J Allergy Clin Immunol 111 2003 743 749
-
(2003)
J Allergy Clin Immunol
, vol.111
, pp. 743-749
-
-
Bochenek, G.1
Nagraba, K.2
Nizankowska, E.3
Szczeklik, A.4
-
5
-
-
77951768969
-
Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers
-
N. Higashi, H. Mita, E. Ono, and et al. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers J Allergy Clin Immunol 125 2010 1084 1091
-
(2010)
J Allergy Clin Immunol
, vol.125
, pp. 1084-1091
-
-
Higashi, N.1
Mita, H.2
Ono, E.3
-
6
-
-
0026644731
-
4, and histamine in asthmatics
-
4, and histamine in asthmatics Am Rev Respir Dis 146 1992 96 103
-
(1992)
Am Rev Respir Dis
, vol.146
, pp. 96-103
-
-
Klumlin, M.1
Dahlen, B.2
Bjorck, T.3
Zetterstrom, O.4
Granstrom, E.5
Dahlen, S.6
-
8
-
-
0027462391
-
Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma
-
K. Sladek, and A. Szczeklik Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma Eur Respir J 6 1993 391 399
-
(1993)
Eur Respir J
, vol.6
, pp. 391-399
-
-
Sladek, K.1
Szczeklik, A.2
-
9
-
-
84908133226
-
Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
-
M. Swierczynska-Krepa, M. Sanak, G. Bochenek, and et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study J Allergy Clin Immunol 134 2014 883 890
-
(2014)
J Allergy Clin Immunol
, vol.134
, pp. 883-890
-
-
Swierczynska-Krepa, M.1
Sanak, M.2
Bochenek, G.3
-
11
-
-
0026760459
-
Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge
-
U.R. Juergens, S.C. Christiansen, D.D. Stevenson, and B.L. Zuraw Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge J Allergy Clin Immunol 90 1992 636 645
-
(1992)
J Allergy Clin Immunol
, vol.90
, pp. 636-645
-
-
Juergens, U.R.1
Christiansen, S.C.2
Stevenson, D.D.3
Zuraw, B.L.4
-
12
-
-
84920389743
-
A dominant mediator of aspirin-exacerbated respiratory disease
-
K.N. Cahill, J.C. Bensko, J.A. Boyce, T.M. Laidlaw, and D. Prostaglandin A dominant mediator of aspirin-exacerbated respiratory disease J Allergy Clin Immunol 135 2015 245 252
-
(2015)
J Allergy Clin Immunol
, vol.135
, pp. 245-252
-
-
Cahill, K.N.1
Bensko, J.C.2
Boyce, J.A.3
Laidlaw, T.M.4
Prostaglandin, D.5
-
13
-
-
84856460001
-
Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis
-
e551-e552
-
N. Higashi, H. Mita, H. Yamaguchi, Y. Fukutomi, K. Akiyama, and M. Taniguchi Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis J Allergy Clin Immunol 129 2012 557 559 e551-e552
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. 557-559
-
-
Higashi, N.1
Mita, H.2
Yamaguchi, H.3
Fukutomi, Y.4
Akiyama, K.5
Taniguchi, M.6
-
15
-
-
59449099804
-
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease
-
A.P. Hope, K.A. Woessner, R.A. Simon, and D.D. Stevenson Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 123 2009 406 410
-
(2009)
J Allergy Clin Immunol
, vol.123
, pp. 406-410
-
-
Hope, A.P.1
Woessner, K.A.2
Simon, R.A.3
Stevenson, D.D.4
-
16
-
-
33846820329
-
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: A practice paper
-
E. Macy, J.A. Bernstein, M.C. Castells, and et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper Ann Allergy Asthma Immunol 98 2007 172 174
-
(2007)
Ann Allergy Asthma Immunol
, vol.98
, pp. 172-174
-
-
Macy, E.1
Bernstein, J.A.2
Castells, M.C.3
-
17
-
-
0021163545
-
Dose-related kinetics of aspirin: Presystemic acetylation of platelet cyclooxygenase
-
A. Pedersen, and G.A. Fitzgerald Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase N Engl J Med 311 1984 1206 1211
-
(1984)
N Engl J Med
, vol.311
, pp. 1206-1211
-
-
Pedersen, A.1
Fitzgerald, G.A.2
-
18
-
-
84946410922
-
An hourly dose-escalation desensitization protocol for aspirin exacerbated respiratory disease
-
J.R. Chen, B.L. Buchmiller, and D.A. Khan An hourly dose-escalation desensitization protocol for aspirin exacerbated respiratory disease J Allergy Clin Immunol Pract 3 2015 926 931.e1
-
(2015)
J Allergy Clin Immunol Pract
, vol.3
, pp. 926-931e1
-
-
Chen, J.R.1
Buchmiller, B.L.2
Khan, D.A.3
-
19
-
-
77957795704
-
The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases
-
R.K. Katial, M. Strand, T. Prasertsuntarasai, R. Leung, W. Zheng, and R. Alam The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases J Allergy Clin Immunol 126 2010 738 744
-
(2010)
J Allergy Clin Immunol
, vol.126
, pp. 738-744
-
-
Katial, R.K.1
Strand, M.2
Prasertsuntarasai, T.3
Leung, R.4
Zheng, W.5
Alam, R.6
-
20
-
-
3442901155
-
Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma
-
G. Rolla, A. Di Emanuele, L. Dutto, and et al. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma Allergy 59 2004 827 832
-
(2004)
Allergy
, vol.59
, pp. 827-832
-
-
Rolla, G.1
Di Emanuele, A.2
Dutto, L.3
-
21
-
-
84871047455
-
Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease
-
D. Tworek, I. Kuprys-Lipinska, W. Pietruszewska, and P. Kuna Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease Am J Rhinol Allergy 26 2012 428 432
-
(2012)
Am J Rhinol Allergy
, vol.26
, pp. 428-432
-
-
Tworek, D.1
Kuprys-Lipinska, I.2
Pietruszewska, W.3
Kuna, P.4
-
22
-
-
33845219390
-
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges
-
A. White, E. Ludington, P. Mehra, D.D. Stevenson, and R.A. Simon Effect of leukotriene modifier drugs on the safety of oral aspirin challenges Ann Allergy Asthma Immunol 97 2006 688 693
-
(2006)
Ann Allergy Asthma Immunol
, vol.97
, pp. 688-693
-
-
White, A.1
Ludington, E.2
Mehra, P.3
Stevenson, D.D.4
Simon, R.A.5
-
23
-
-
26944473225
-
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease
-
A.A. White, D.D. Stevenson, and R.A. Simon The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 95 2005 330 335
-
(2005)
Ann Allergy Asthma Immunol
, vol.95
, pp. 330-335
-
-
White, A.A.1
Stevenson, D.D.2
Simon, R.A.3
-
24
-
-
0027564322
-
Lung volumes and forced ventilatory flows: Report of the Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: Official Statement of the European Respiratory Society
-
P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows: report of the Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: Official Statement of the European Respiratory Society Eur Respir J 16 suppl 1993 5 40
-
(1993)
Eur Respir J
, vol.16
, pp. 5-40
-
-
Quanjer, P.H.1
Tammeling, G.J.2
Cotes, J.E.3
Pedersen, O.F.4
Peslin, R.5
Yernault, J.C.6
-
25
-
-
84962331075
-
-
Clement Clarke International Ltd Clement Clarke International Ltd Harlow, United Kingdom
-
Clement Clarke International Ltd Clement Clarke International Catalogue 2015 Clement Clarke International Ltd Harlow, United Kingdom
-
(2015)
Clement Clarke International Catalogue
-
-
-
26
-
-
84962226992
-
-
Cayman Chemical Ann Arbor, MI
-
Cayman Chemical, Inc Cystenyl Leukotriene EIA Kit 2010 Cayman Chemical Ann Arbor, MI
-
(2010)
Cystenyl Leukotriene EIA Kit
-
-
-
27
-
-
84962261557
-
-
Cayman Chemical Ann Arbor, MI
-
Cayman Chemical, Inc Tetranor-PGDM EIA Kit 2010 Cayman Chemical Ann Arbor, MI
-
(2010)
Tetranor-PGDM EIA Kit
-
-
-
28
-
-
84962254256
-
-
Cayman Chemical Ann Arbor, MI
-
Cayman Chemical, Inc Prostaglandin E Metabolite EIA Kit 2010 Cayman Chemical Ann Arbor, MI
-
(2010)
Prostaglandin e Metabolite EIA Kit
-
-
-
29
-
-
0037253429
-
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease
-
M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 111 2003 180 186
-
(2003)
J Allergy Clin Immunol
, vol.111
, pp. 180-186
-
-
Berges-Gimeno, M.P.1
Simon, R.A.2
Stevenson, D.D.3
-
30
-
-
80052438246
-
An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications
-
R.A. Dweik, P.B. Boggs, S.C. Erzurum, and et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am J Respir Crit Care Med 184 2011 602 615
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 602-615
-
-
Dweik, R.A.1
Boggs, P.B.2
Erzurum, S.C.3
-
31
-
-
84906944492
-
Exhaled nitric oxide: A biomarker integrating both lung function and airway inflammation changes
-
A. Haccuria, A. Michils, S. Michiels, and A. Van Muylem Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes J Allergy Clin Immunol 134 2014 554 559
-
(2014)
J Allergy Clin Immunol
, vol.134
, pp. 554-559
-
-
Haccuria, A.1
Michils, A.2
Michiels, S.3
Van Muylem, A.4
-
32
-
-
84896509428
-
Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS
-
A.B. Roos, M. Mori, R. Gronneberg, and et al. Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS PloS One 9 2014 e90018
-
(2014)
PloS One
, vol.9
, pp. e90018
-
-
Roos, A.B.1
Mori, M.2
Gronneberg, R.3
-
33
-
-
84902244482
-
Current evidence and future research needs for FeNO measurement in respiratory diseases
-
L. Bjermer, K. Alving, Z. Diamant, and et al. Current evidence and future research needs for FeNO measurement in respiratory diseases Respir Med 108 2014 830 841
-
(2014)
Respir Med
, vol.108
, pp. 830-841
-
-
Bjermer, L.1
Alving, K.2
Diamant, Z.3
-
34
-
-
0027752805
-
The l-arginine-nitric oxide pathway
-
S. Moncada, and A. Higgs The l-arginine-nitric oxide pathway N Engl J Med 329 1993 2002 2012
-
(1993)
N Engl J Med
, vol.329
, pp. 2002-2012
-
-
Moncada, S.1
Higgs, A.2
-
35
-
-
84903273768
-
Relationship between methacholine challenge testing and exhaled nitric oxide in adult patients with suspected bronchial asthma
-
M. Giovannini, M. Valli, V. Ribuffo, and et al. Relationship between methacholine challenge testing and exhaled nitric oxide in adult patients with suspected bronchial asthma Eur Annals Allergy Clin Immunol 46 2014 109 113
-
(2014)
Eur Annals Allergy Clin Immunol
, vol.46
, pp. 109-113
-
-
Giovannini, M.1
Valli, M.2
Ribuffo, V.3
-
36
-
-
84918546420
-
Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury
-
F. Wu, W.S. Szczepaniak, S. Shiva, and et al. Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury Am J Physiol Lung Cell Mol Physiol 307 2014 L987 L997
-
(2014)
Am J Physiol Lung Cell Mol Physiol
, vol.307
, pp. L987-L997
-
-
Wu, F.1
Szczepaniak, W.S.2
Shiva, S.3
-
37
-
-
0031889921
-
Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury
-
E.A. Lianos, K. Guglielmi, and M. Sharma Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury Kidney Int 53 1998 645 653
-
(1998)
Kidney Int
, vol.53
, pp. 645-653
-
-
Lianos, E.A.1
Guglielmi, K.2
Sharma, M.3
-
38
-
-
1142285212
-
Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis
-
N. Higashi, M. Taniguchi, H. Mita, and et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis J Allergy Clin Immunol 113 2004 277 283
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 277-283
-
-
Higashi, N.1
Taniguchi, M.2
Mita, H.3
-
39
-
-
0029664976
-
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma
-
P. Sestini, L. Armetti, G. Gambaro, and et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma Am J Respir Crit Care Med 153 1996 572 575
-
(1996)
Am J Respir Crit Care Med
, vol.153
, pp. 572-575
-
-
Sestini, P.1
Armetti, L.2
Gambaro, G.3
-
40
-
-
84903596067
-
Aspirin activation of eosinophils and mast cells: Implications in the pathogenesis of aspirin-exacerbated respiratory disease
-
J.W. Steinke, J. Negri, L. Liu, S.C. Payne, and L. Borish Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease J Immunol 193 2014 41 47
-
(2014)
J Immunol
, vol.193
, pp. 41-47
-
-
Steinke, J.W.1
Negri, J.2
Liu, L.3
Payne, S.C.4
Borish, L.5
-
41
-
-
0034063822
-
Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients
-
M.L. Kowalski, R. Pawliczak, J. Wozniak, and et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients Am J Respir Crit Care Med 161 2000 391 398
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 391-398
-
-
Kowalski, M.L.1
Pawliczak, R.2
Wozniak, J.3
-
42
-
-
84901802659
-
2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease
-
2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 133 2014 1692 1701.e1693
-
(2014)
J Allergy Clin Immunol
, vol.133
, pp. 1692-1701e1693
-
-
Laidlaw, T.M.1
Cutler, A.J.2
Kidder, M.S.3
-
43
-
-
84885693969
-
Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes
-
T. Liu, T.M. Laidlaw, H.R. Katz, and J.A. Boyce Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes Proc Natl Acad Sci U S A 110 2013 16987 16992
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. 16987-16992
-
-
Liu, T.1
Laidlaw, T.M.2
Katz, H.R.3
Boyce, J.A.4
-
44
-
-
79959829982
-
Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma
-
J. Roca-Ferrer, F.J. Garcia-Garcia, J. Pereda, and et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma J Allergy Clin Immunol 128 2011 66 72.e61
-
(2011)
J Allergy Clin Immunol
, vol.128
, pp. 66-72e61
-
-
Roca-Ferrer, J.1
Garcia-Garcia, F.J.2
Pereda, J.3
-
45
-
-
59549107363
-
Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma
-
T. Yoshimura, M. Yoshikawa, N. Otori, S. Haruna, and H. Moriyama Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma Allergol Intl 57 2008 429 436
-
(2008)
Allergol Intl
, vol.57
, pp. 429-436
-
-
Yoshimura, T.1
Yoshikawa, M.2
Otori, N.3
Haruna, S.4
Moriyama, H.5
|